According to a report released by the Centers for Disease Control and Prevention and the Nevada State Health Division Bureau, the 2008 hepatitis C outbreak at a Las Vegas colonoscopy clinic and associated properties was “preventable” and “costly.” The combined cost of the investigation, counseling and testing associated with the outbreak is an estimated $16.3 million to $21.9 million.
The report said that the endoscopy staff of the Endoscopy Center of Southern Nevada and related clinics should have adhered to "well-established, safe, and common-sense injection practices."
Nine cases of hepatitis C were linked to the clinics, and 106 additional cases were considered possibly related. More than 50,000 people were told that they may have been exposed to hepatitis C, hepatitis B and HIV.
To read the report, CLICK HERE.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.